Yahoo Finance 
Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, March 15, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Industry" - https://www.reportlinker.com/p06361342/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$4.6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at aCAGR of 6.7% over the period 2022-2030. Hemostats, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Internal Tissue Sealants segment is readjusted to a revised 6.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 11.3% CAGR
The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Select Competitors (Total 44 Featured)
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.
Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Surgical Hemostats, Internal Tissue Sealants, and Adhesion
Barriers - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Hemostats by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Hemostats by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 6: World 16-Year Perspective for Hemostats by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Internal Tissue Sealants by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Internal Tissue Sealants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Internal Tissue Sealants
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Adhesion Barriers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Adhesion Barriers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Adhesion Barriers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Surgical Repair Applications by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Surgical Repair
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Surgical Repair
Applications by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Trauma Cases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Trauma Cases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 18: World 16-Year Perspective for Trauma Cases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 21: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for
Specialty Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Specialty Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 24: World 16-Year Perspective for Specialty Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 25: World Surgical Hemostats, Internal Tissue Sealants
and Adhesion Barriers Market Analysis of Annual Sales in US$
Million for Years 2014 through 2030
Table 26: World Recent Past, Current & Future Analysis for
Ambulatory Surgery Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
III. MARKET ANALYSIS
UNITED STATES
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 32: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 34: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 35: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 36: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by End-Use - Hospitals,
Ambulatory Surgery Centers and Specialty Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 37: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 40: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 41: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 42: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 43: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 44: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 45: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 46: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
JAPAN
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 48: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 49: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 50: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 51: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 52: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 53: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 54: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 55: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
CHINA
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 58: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 59: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 60: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 61: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 62: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 63: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 64: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
EUROPE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR
Table 66: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 67: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2014, 2023 & 2030
Table 68: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 69: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 70: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 71: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 72: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 73: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 74: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 75: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 76: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
FRANCE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 78: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 79: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 80: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 81: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 82: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 83: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 84: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 85: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
GERMANY
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 87: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 88: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 89: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 90: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 91: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 92: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 93: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 94: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 96: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 97: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 98: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 99: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 100: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 101: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 102: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 103: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030
UNITED KINGDOM
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR
Table 105: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 106: UK 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030
Table 107: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 108: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 109: UK 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030
Table 110: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
